What is the recommended dose and frequency of Nitrofurantoin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Nitrofurantoin is recommended at a dose of 100 mg twice daily for 5 days for the treatment of uncomplicated urinary tract infections.

Key Points

  • The recommended dose and frequency of Nitrofurantoin is 100 mg twice daily for 5 days 1.
  • This regimen has been shown to have comparable efficacy to 3 days of trimethoprim-sulfamethoxazole 1.
  • Nitrofurantoin has minimal resistance and propensity for collateral damage, making it an appropriate choice for therapy 1.
  • The clinical cure rate with Nitrofurantoin is 88% - 93% and the bacterial cure rate is 81% - 92% 1.
  • Other studies have also recommended Nitrofurantoin 100 mg PO every 6 h for the treatment of uncomplicated urinary tract infections due to multidrug-resistant organisms, but this is based on weak recommendation and very low quality of evidence 1.
  • However, in the context of real-life clinical medicine, the dose of 100 mg twice daily for 5 days is preferred due to its established efficacy and safety profile.

From the Research

Recommended Dose and Frequency of Nitrofurantoin

  • The recommended dose and frequency of Nitrofurantoin vary depending on the specific use case, such as treatment or prophylaxis of urinary tract infections (UTIs) 2, 3, 4, 5, 6.
  • For the treatment of uncomplicated lower urinary tract infections, a dose of 100 mg three times a day for 5 days is commonly used 2, 3.
  • A study comparing 5-day Nitrofurantoin with single-dose Fosfomycin found that Nitrofurantoin resulted in a significantly greater likelihood of clinical and microbiologic resolution at 28 days after therapy completion 3.
  • For prophylaxis of UTIs, a daily dose of 50 mg or 100 mg is used, with some studies suggesting that 50 mg may have a better safety profile 4, 6.
  • A cohort study found that daily prophylaxis with 100 mg instead of 50 mg Nitrofurantoin was associated with an equivalent hazard on UTI or pyelonephritis, but a higher hazard on cough, dyspnea, and nausea 6.

Special Considerations

  • In patients with renal insufficiency, Nitrofurantoin may still be effective, but its use should be carefully considered, as its efficacy may be decreased in patients with severe renal impairment 5.
  • The duration of Nitrofurantoin prophylaxis may also impact its safety, with longer durations potentially increasing the risk of severe adverse effects 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Nitrofurantoin's efficacy and safety as prophylaxis for urinary tract infections: a systematic review of the literature and meta-analysis of controlled trials.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2017

Research

Nitrofurantoin safety and effectiveness in treating acute uncomplicated cystitis (AUC) in hospitalized adults with renal insufficiency: antibiotic stewardship implications.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017

Research

Nitrofurantoin 100 mg versus 50 mg prophylaxis for urinary tract infections, a cohort study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.